# Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema

> **NCT00318513** · PHASE1 · UNKNOWN · sponsor: **Premiere Oncology of Arizona** · enrollment: 35 (—)

## Conditions studied

- Lymphedema

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT00318513
- **Lead sponsor:** Premiere Oncology of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 35 (—)
- **Last updated:** 2006-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00318513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00318513, "Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00318513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*